When discussing cholesterol, many people hear the terms “good cholesterol” and “bad cholesterol.”
In reality, cholesterol itself is neither good nor bad—the key difference lies in how it is transported and used in the body.
Have you ever seen LDL and HDL on a health report but weren’t sure what they mean?
Understanding the difference between them is an important step in recognizing lipid balance.
High-dose intravenous vitamin C (HDIVC), also known as pharmacological ascorbate, has re-emerged in oncology research as a promising adjunctive supportive therapy. While it is not a standalone cure for cancer, clinical studies indicate that when administered at appropriate pharmacological doses, it can provide meaningful benefits for some patients—including improved survival in specific contexts, better quality of life (QoL), and reduced chemotherapy-related side effects. However, not every patient experiences the same level of improvement. This variability is not necessarily evidence that HDIVC “does not work,” but often reflects differences in how the therapy is implemented: dosage, frequency, integration with other treatments, practitioner expertise, and individual patient factors. The same method can yield very different outcomes depending on these variables.
In cholesterol management, people are often concerned not only about whether a method exists, but also:
Can it be maintained consistently?
Is it suitable for long-term management?
Can the body adapt to it over time?
With the emergence of newer approaches such as LEQVIO (Inclisiran),
the conversation is gradually shifting from short-term changes to long-term management outcomes.
So, based on publicly available clinical data, how should we understand its effectiveness and safety?
For many people, elevated cholesterol is first discovered during a routine health check.
Even when the numbers are abnormal, there may be no obvious symptoms, which often leads to it being overlooked.
So why does cholesterol increase?
Is it really just about “eating too much fat”?
From a cellular and metabolic perspective, changes in cholesterol are closely related to overall lipid balance, liver regulation, and lifestyle factors.
Lasix (Furosemide) is a commonly used potent diuretic (often referred to as a “water pill”). Its generic name is furosemide, and it belongs to the class of loop diuretics.
Below is a refined and structured version of your original content, with all key information preserved and presented more clearly and professionally.
High cholesterol—especially elevated low-density lipoprotein cholesterol (LDL-C, or “bad” cholesterol)—is a common cardiovascular risk factor in Hong Kong. If left unmanaged, it can lead to atherosclerosis, heart disease, or stroke. Many people struggle to reach target LDL-C levels even with maximum tolerated statin therapy, or they experience side effects like muscle pain or liver concerns that make daily pills hard to stick with.
Shingles Vaccine (commonly known as “snake shot” or “herpes zoster vaccine”) is used to prevent shingles (herpes zoster). The most commonly recommended and used vaccine in Hong Kong (and globally) is the second-generation recombinant vaccine: Shingrix (Recombinant Zoster Vaccine, adjuvanted, produced by GSK).
During the recovery phase after treatment, some people may notice that their heartbeat feels more noticeable than before.
For example, while sitting quietly they may become aware of their heartbeat in the chest, or after mild activities such as walking or climbing stairs, the heartbeat may feel more pronounced.
Some individuals even describe it as being able to clearly feel their heartbeat, yet medical examinations often do not reveal any obvious abnormalities.
This situation is not uncommon during the recovery period and is usually related to the body’s gradual process of adjustment and recovery.
During or after treatment, some individuals notice that their skin becomes drier than before. It may also feel itchy, slightly flaky, or more sensitive.
Some people find that skincare products they used comfortably in the past suddenly feel unsuitable, or that their skin reacts more strongly to weather changes.
These changes are not uncommon during the recovery phase and are often related to temporary adjustments in the skin’s barrier function.
During or after treatment, some individuals notice that foods they once enjoyed no longer taste the same. Flavors may seem bland, bitter, or even metallic.
Some people do not lack the desire to eat, but rather feel unable to tolerate food, or find that eating has become uncomfortable.
This change is often underestimated, yet it can have a significant impact during the recovery phase.